| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2004 | US20040068006 Method for preventing acute renal failure |
| 04/08/2004 | US20040068003 Compounds useful for the inhibition of ALDH |
| 04/08/2004 | US20040068002 4-aminobenzopyran derivatives |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040068000 Compression coated tablets |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067998 Oral administering |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
| 04/08/2004 | US20040067993 Famotidine injections |
| 04/08/2004 | US20040067992 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067988 Anticoagulants |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067986 Selegiline or procaine hydrochloride; vinpocetin with niacin, niacinamide or aminobutyric acid |
| 04/08/2004 | US20040067985 Anticancer agents |
| 04/08/2004 | US20040067984 Psychological disorders; central nervous system disorders; cognition activators |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067978 Central nervous system disorders; Down's syndrome; autism |
| 04/08/2004 | US20040067977 Tropane derivatives useful in therapy |
| 04/08/2004 | US20040067973 N-substituted hydromorphones and the use thereof |
| 04/08/2004 | US20040067971 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067968 Antitumor, anticancer agents |
| 04/08/2004 | US20040067967 Controlling adenosine triphosphatase gene expression |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067965 Viricides; cytomegalo virus |
| 04/08/2004 | US20040067963 Post-trauma stress disorders; administering serotinine reuptake inhibitor |
| 04/08/2004 | US20040067962 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067958 Process for hydroxyazapirones |
| 04/08/2004 | US20040067957 Methods of treating or preventing restless leg syndrome using sibutramine metabolites |
| 04/08/2004 | US20040067956 Treatment of motor fluctuations |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067952 Method and composition for treatment of cancer |
| 04/08/2004 | US20040067950 High affinity ligands for nociceptin receptor ORL-1 |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067947 Atherosclerosis; restenosis; cardiovascular disorders; immunosuppresants |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067942 Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | US20040067934 Use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067931 Benzimidazolidinone derivatives as muscarinic agents |
| 04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
| 04/08/2004 | US20040067929 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040067926 Sustained-release suspension of ceftiofur hydrochloride |
| 04/08/2004 | US20040067925 Multilayer tablet containing amyoxycillin, or sodium salt thereof |
| 04/08/2004 | US20040067923 Use of biogenic estriol sulfamate prodrugs for treatment of autoimmune diseases |
| 04/08/2004 | US20040067922 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/08/2004 | US20040067921 Anticholesterol agents |
| 04/08/2004 | US20040067920 Mixing with carrier; controlling particle sizes |
| 04/08/2004 | US20040067919 Aqueous solution with nonionic surfactant; mixing, heating, cooling; oil in water emulsion |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067917 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 04/08/2004 | US20040067916 Method for treating, inhibiting or preventing pathogenic change resulting from vascular injury with an aldosterone antagonist |
| 04/08/2004 | US20040067912 Microbiocides, antibiotic, antitumor agent |
| 04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 04/08/2004 | US20040067908 Using lysophosphatidic acid receptor controllers |
| 04/08/2004 | US20040067902 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067899 Administering glycyrrhizin, or salt thereof |
| 04/08/2004 | US20040067898 Synthesis and separation of optically active isomers of erythromycin and their biological actions |
| 04/08/2004 | US20040067894 Preparation having antioxidant properties |
| 04/08/2004 | US20040067893 Adenocarcinogenic agent |
| 04/08/2004 | US20040067892 Fullerene derivative and composition comprising the same |
| 04/08/2004 | US20040067891 Therapeutic and/or preventive agents for diseases due to retinal ischemia |
| 04/08/2004 | US20040067890 Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions |
| 04/08/2004 | US20040067886 Reducing pain; administering protein kinase c inhibitor; side effect reduction |
| 04/08/2004 | US20040067883 Prevent gene expression; anticancer agents |
| 04/08/2004 | US20040067877 Hepatitis virus infections |
| 04/08/2004 | US20040067873 Compolex of apolipoproteins and sphingomyelins; anticholesterol agents |
| 04/08/2004 | US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 04/08/2004 | US20040067871 Detection of polymorphism alleles in labeled chromosome |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067263 Treatment of liver cancer, adenocarcinoma of stomach, lung cancer, and breast carcinoma. |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067257 Pharmaceutical formulation |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067255 Especially a phosphate prodrug salt of combretastatin A-4; treating diseases associated with malignant neovascularization. |
| 04/08/2004 | US20040067254 Paroxetine compositions and processes for making the same |
| 04/08/2004 | US20040067253 Pharmaceutical preparation, method for its production as well as its use |
| 04/08/2004 | US20040067252 Novel modified release formulation |